生物胺和氨基酸GABA和谷氨酸:与疼痛和抑郁的关系。

Modern trends in pharmacopsychiatry Pub Date : 2015-01-01 Epub Date: 2015-09-18 DOI:10.1159/000435933
Curtis Benson, Katherine Mifflin, Bradley Kerr, Sam J B Jesudasan, Serdar Dursun, Glen Baker
{"title":"生物胺和氨基酸GABA和谷氨酸:与疼痛和抑郁的关系。","authors":"Curtis Benson,&nbsp;Katherine Mifflin,&nbsp;Bradley Kerr,&nbsp;Sam J B Jesudasan,&nbsp;Serdar Dursun,&nbsp;Glen Baker","doi":"10.1159/000435933","DOIUrl":null,"url":null,"abstract":"<p><p>Although it is well known that there is a high degree of comorbidity between chronic pain and mood and anxiety disorders, the mechanisms involved in these co-occurrences are not clear. It appears that numerous neurotransmitters and neuromodulators are involved, and this chapter focuses on the monoamine neurotransmitters noradrenaline, 5-hydroxytryptamine (5-HT, serotonin), and dopamine and the amino acid neurotransmitters GABA (γ-aminobutyric acid) and glutamate in chronic pain and depression. Numerous preclinical and clinical neurochemical, neuroanatomical, pharmacological and molecular biological studies as well as clinical pharmacological treatment investigations implicate noradrenaline, 5-HT and, to a lesser extent, dopamine in the etiology of pain and depression. Similarly, preclinical and clinical studies on GABAergic and glutamatergic mechanisms as well as reports on the actions of neuroactive steroids suggest that GABA and glutamate play an important role in the etiology of pain and depression and may contribute to comorbidity.</p>","PeriodicalId":74212,"journal":{"name":"Modern trends in pharmacopsychiatry","volume":"30 ","pages":"67-79"},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000435933","citationCount":"41","resultStr":"{\"title\":\"Biogenic Amines and the Amino Acids GABA and Glutamate: Relationships with Pain and Depression.\",\"authors\":\"Curtis Benson,&nbsp;Katherine Mifflin,&nbsp;Bradley Kerr,&nbsp;Sam J B Jesudasan,&nbsp;Serdar Dursun,&nbsp;Glen Baker\",\"doi\":\"10.1159/000435933\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Although it is well known that there is a high degree of comorbidity between chronic pain and mood and anxiety disorders, the mechanisms involved in these co-occurrences are not clear. It appears that numerous neurotransmitters and neuromodulators are involved, and this chapter focuses on the monoamine neurotransmitters noradrenaline, 5-hydroxytryptamine (5-HT, serotonin), and dopamine and the amino acid neurotransmitters GABA (γ-aminobutyric acid) and glutamate in chronic pain and depression. Numerous preclinical and clinical neurochemical, neuroanatomical, pharmacological and molecular biological studies as well as clinical pharmacological treatment investigations implicate noradrenaline, 5-HT and, to a lesser extent, dopamine in the etiology of pain and depression. Similarly, preclinical and clinical studies on GABAergic and glutamatergic mechanisms as well as reports on the actions of neuroactive steroids suggest that GABA and glutamate play an important role in the etiology of pain and depression and may contribute to comorbidity.</p>\",\"PeriodicalId\":74212,\"journal\":{\"name\":\"Modern trends in pharmacopsychiatry\",\"volume\":\"30 \",\"pages\":\"67-79\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1159/000435933\",\"citationCount\":\"41\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Modern trends in pharmacopsychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000435933\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2015/9/18 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Modern trends in pharmacopsychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000435933","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2015/9/18 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 41

摘要

虽然众所周知,慢性疼痛与情绪和焦虑障碍之间存在高度的共病,但这些共病的机制尚不清楚。似乎有许多神经递质和神经调节剂参与其中,本章主要讨论单胺类神经递质去甲肾上腺素、5-羟色胺(5-HT、5-羟色胺)和多巴胺以及氨基酸类神经递质GABA (γ-氨基丁酸)和谷氨酸在慢性疼痛和抑郁中的作用。大量的临床前和临床神经化学、神经解剖学、药理学和分子生物学研究以及临床药理学治疗调查表明,去甲肾上腺素、5-羟色胺和多巴胺在疼痛和抑郁的病因学中有一定的作用。同样,关于GABA能和谷氨酸能机制的临床前和临床研究以及关于神经活性类固醇作用的报道表明,GABA和谷氨酸在疼痛和抑郁的病因中起着重要作用,并可能导致合并症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Biogenic Amines and the Amino Acids GABA and Glutamate: Relationships with Pain and Depression.

Although it is well known that there is a high degree of comorbidity between chronic pain and mood and anxiety disorders, the mechanisms involved in these co-occurrences are not clear. It appears that numerous neurotransmitters and neuromodulators are involved, and this chapter focuses on the monoamine neurotransmitters noradrenaline, 5-hydroxytryptamine (5-HT, serotonin), and dopamine and the amino acid neurotransmitters GABA (γ-aminobutyric acid) and glutamate in chronic pain and depression. Numerous preclinical and clinical neurochemical, neuroanatomical, pharmacological and molecular biological studies as well as clinical pharmacological treatment investigations implicate noradrenaline, 5-HT and, to a lesser extent, dopamine in the etiology of pain and depression. Similarly, preclinical and clinical studies on GABAergic and glutamatergic mechanisms as well as reports on the actions of neuroactive steroids suggest that GABA and glutamate play an important role in the etiology of pain and depression and may contribute to comorbidity.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders. The Link between Refractoriness and Neuroprogression in Treatment-Resistant Bipolar Disorder. The Contribution of Adult Hippocampal Neurogenesis to the Progression of Psychiatric Disorders. Neurodegeneration, Neuroregeneration, and Neuroprotection in Psychiatric Disorders. Pharmacological and Nonpharmacological Interventions to Arrest Neuroprogression in Psychiatric Disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1